CHDR values fruitful collaborations with partners throughout the Netherlands.

Medical Centres in the Netherlands

CHDR is located in the heart of the Leiden Bio Science Park, which lays in the middle of the Randstad area (one of the largest conurbations in Europe). The conurbation consists of the four largest Dutch cities and the surrounding areas, and is considered the most densely populated area in the Netherlands. CHDR’s unique location and collaborations with the top medical centers in the country provide a rich environment for exchange of knowledge and at the same time recruitment of different patient populations.

Leiden University Medical Center

CHDR originates from Leiden University (LU) and Leiden University Medical Center (LUMC), what results in a strong, long standing collaboration between CHDR and LUMC. This gives us direct access to an extensive knowledge base in Leiden and at the same time access to different patient populations.

Erasmus University Medical Center

Erasmus MC in Rotterdam is the largest and most versatile of the eight university medical centers in the Netherlands. We have a pulmonary collaboration (Asthma, COPD, Fibrosis) with Erasmus MC, and work together with Prof . Henk C. Hoogsteden, Professor of Pulmonary Diseases and Tuberculosis.

Amsterdam University Medical Centers 

Amsterdam UMC is one of the largest and leading hospitals of The Netherlands. We have a vascular medicine and inflammation collaboration (atherosclerosis, associated inflammation, lipids), and work together with: 

  • Prof. Dr. Erik Stroes, MD - Chair Department of Vascular medicine
  • Prof. Dr. John J.P. Kastelein Professor of Medicine and Chairman of the Department of Vascular Medicine

Clinical Network for Trials in Dermatology

Clinical trials are regularly performed at CHDR in close collaboration with the Clinical Network for Trials in Dermatology - a new network of dermatologists with strong interest in science and education, in which more than 170 dermatologists of academic hospitals and peripheral clinics participate. Involved parties include:

  • Leiden University Medical Center (LUMC), Leiden
  • Erasmus University Medical Center, Rotterdam
  • Free University Medical Center, Amsterdam
  • Teaching hospitals, Skin and Beauty therapists

Clinical and Laboratory Chronic Hepatitis B Research Consortium 

Experts from Amsterdam University Medical Centers (Amsterdam UMC), Leiden University Medical Center (LUMC) and Centre for Human Drug Research (CHDR) have established a clinical and laboratory research consortium with the aim of ultimately finding a cure for Chronic Hepatitis B (CHB). Click here for more information 

The consortium is interested to collaborate with other parties, e.g., companies developing new drugs against CHB or CHD, or academic or other hospitals interested in HBV research. 

Contact:, and 


The GMP-licensed pharmacy of the Leiden University Medical Center (LUMC) is responsible for all pharmacy related activities of clinical trials at CHDR.

More information: CHDR Pharmacy

Collaborations for laboratory & analytical services

Good Biomarker Sciences 

Good Biomarker Sciences (GBS) is specialized in fit-for-purpose functional bioassays applied to clinical studies, in the fields of haemostasis, immunity and cellular stress. We also perform biomarker validation across clinical, population and in vitro studies.

The laboratory is housed in CHDR's clinical research unit. GBS is a successful spinout organisation from TNO (Netherlands Organisation for Applied Scientific Research) with over 30 years of experience.

GBS conducts research laboratory services for the study of biomarkers, as well as provides advice on the selection of biomarkers for research protocols, the validation and devising of (new) tests and execution of assay series.

We also continuously work on our own research projects to expand our capabilities, with particular emphasis on bringing advanced techniques required to unravel complex biological responses in humans to clinical trials. Current research at GBS is focused on contact activation, new coagulation inhibitors, as well as immunity and inflammation related targets.

GBS works with Good Clinical Laboratory Practice guidelines and maintains high quality standards in documentation and customer focus.

Contact CHDR